INCYTE CORP

INCY 10-K · Q4 2025
API behind this page

INCY Q4 2025 request

Playground key active
Request URL /api/financials?ticker=INCY&year=2025&quarter=4
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q4 2025 Q4 2024 YoY
Revenue 1,506,835 1,178,698 +27.8%
Show Product Lines breakouts
ICLUSIG 34,216 27,369 +25.0%
JAKAFI 828,244 773,114 +7.1%
JAKAFI · US 20.3 37.9 -46.4%
JAKAVI Royalty Revenues 130,225 114,187 +14.0%
JAKAVI · Novartis 130.2 114.1 +14.1%
Milestone and contract revenues 100,000 0 —
Milestone and contract revenues · Reportable Segment 100,000 0 —
MINJUVI/MONJUVI 41,906 32,807 +27.7%
OLUMIANT · Eli Lilly 43.2 38.5 +12.2%
OPZELURA 207,283 161,602 +28.3%
Other product royalty revenues 3,470 333 +942.0%
Product 1,222,789 1,019,407 +20.0%
Product · Reportable Segment 1,222,789 1,019,407 +20.0%
Royalty 184,046 159,291 +15.5%
Royalty · Reportable Segment 184,046 159,291 +15.5%
TABRECTA Royalty Revenues 7,144 6,286 +13.6%
TABRECTA · Novartis 7.1 6.2 +14.5%
ZYNYZ 31,747 1,373 +2212.2%
Show Business Segments breakouts
Reportable Segment 1,506,835 1,178,698 +27.8%
Show Geography breakouts
Europe 75,990 88,856 -14.5%
Other countries 6,075 2,508 +142.2%
US 1,424,770 1,087,334 +31.0%
Show — breakouts
Revenue 43,207 38,485 +12.3%
Revenue -14,666 -15,339 +4.4%
Cost of Revenue 121,175 88,485 +36.9%
Show Business Segments breakouts
Reportable Segment 121,175 88,485 +36.9%
Research & Development 611,372 466,034 +31.2%
Show Type Of Arrangement breakouts
Syndax 5.6 1.2 +366.7%
Selling, General & Administrative 390,412 326,710 +19.5%
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 -28,258 -4,044 -598.8%
Show Business Segments breakouts
Reportable Segment -28,258 -4,044 -598.8%
Total Costs & Expenses 1,170,976 877,185 +33.5%
Operating Income 335,859 301,513 +11.4%
Interest Income 30,754 21,198 +45.1%
Interest Expense -582 -419 -38.9%
Equity Securities Fv Ni Gain Loss 18,246 -10,181 +279.2%
Other Non-Operating Income (Expense) 5,664 1,613 +251.1%
Income Before Taxes 389,941 313,724 +24.3%
Income Tax Expense (Benefit) 90,662 112,512 -19.4%
Net Income 299,279 201,212 +48.7%
Show Business Segments breakouts
Reportable Segment 299,279 201,212 +48.7%
EPS (Basic) 1.51 0.96 +57.3%
EPS (Diluted) 1.46 0.95 +53.7%
Wtd Avg Shares (Basic) 745 -4,653 +116.0%
Wtd Avg Shares (Diluted) 1,295 -1,233 +205.0%
Sales & Marketing (Q) — — —
Show Business Segments breakouts
Reportable Segment 308,489 257,532 +19.8%
General & Administrative (Q) — — —
Show Business Segments breakouts
Reportable Segment 81,923 69,178 +18.4%
Comprehensive Income 310,186 172,436 +79.9%
Other Comprehensive Income 10,907 -28,776 +137.9%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 10,285 -10,268 +200.2%
Accumulated Net Unrealized Investment Gain Loss 306 -2,968 +110.3%
Accumulated Translation Adjustment 316 -15,540 +102.0%
Net Income Loss Available To Common Stockholders Basic 299,279 201,212 +48.7%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 3,097,817 1,687,829 +83.5%
Debt Securities Available For Sale Excluding Accrued Interest Current 482,787 470,263 +2.7%
Accounts Receivable Net 1,024,407 853,154 +20.1%
Inventory 101,060 58,872 +71.7%
Prepaid Expenses & Other Current Assets 317,831 168,912 +88.2%
Total Current Assets 5,023,902 3,239,030 +55.1%
Non-Current Assets
Restricted Cash Noncurrent 1,852 1,622 +14.2%
Equity Securities F V N I Noncurrent 47,991 18,814 +155.1%
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level1 47,991 18,814 +155.1%
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts
Investment in Prelude 18.1 — —
Investment in Syndax 29.9 18.8 +59.0%
Show Fair Value By Measurement Basis breakouts
Estimate Of Fair Value Fair Value Disclosure 47,991 18,814 +155.1%
Inventory Noncurrent 342,232 348,327 -1.7%
Property, Plant & Equipment 730,885 763,411 -4.3%
Show Geography breakouts
CH 309,802 277,623 +11.6%
Other countries 14,254 11,693 +21.9%
US 406,829 474,095 -14.2%
Goodwill 133,000 155,593 -14.5%
Deferred Tax Assets 515,294 762,071 -32.4%
Other Non-Current Assets 18,166 10,848 +67.5%
Total Assets 6,957,973 5,444,322 +27.8%
Intangible Assets (Q) — — —
Show Finite Lived Intangible Assets By Major Class breakouts
Capitalized milestone payments 52,522 26,680 +96.9%
Intellectual Property 64,609 86,146 -25.0%
Other Assets
Finance Lease Right Of Use Asset 27,520 30,803 -10.7%
Other Intangible Assets Net 117,131 113,803 +2.9%
Current Liabilities
Accounts Payable 209,938 197,465 +6.3%
Employee Related Liabilities Current 228,071 188,677 +20.9%
Accrued Liabilities 1,031,501 1,212,048 -14.9%
Finance Lease Liability Current 4,516 4,419 +2.2%
Business Combination Contingent Consideration Liability Current 41,144 39,238 +4.9%
Total Current Liabilities 1,515,170 1,641,847 -7.7%
Non-Current Liabilities
Business Combination Contingent Consideration Liability Noncurrent 79,856 153,762 -48.1%
Finance Lease Liability Noncurrent 30,199 33,542 -10.0%
Other Non-Current Liabilities 165,270 167,543 -1.4%
Total Liabilities 1,790,495 1,996,694 -10.3%
Operating Lease Liabilities 14,508 16,793 -13.6%
Stockholders' Equity
Common Stock 198 193 +2.6%
Additional Paid In Capital Common Stock 4,928,049 4,533,437 +8.7%
Accumulated Other Comprehensive Income 25,462 -13,121 +294.1%
Retained Earnings 213,769 -1,072,881 +119.9%
Total Stockholders' Equity 5,167,478 3,447,628 +49.9%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -27,965 -39,923 +30.0%
Accumulated Net Unrealized Investment Gain Loss 1,994 346 +476.3%
Accumulated Other Comprehensive Income 25,462 -13,121 +294.1%
Accumulated Translation Adjustment 51,433 26,456 +94.4%
Additional Paid In Capital 4,928,049 4,533,437 +8.7%
Common Stock 198 193 +2.6%
Retained Earnings 213,769 -1,072,881 +119.9%
Total Liabilities & Equity 6,957,973 5,444,322 +27.8%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Net Income 299,279 201,212 +48.7%
Depreciation & Amortization 23,982 22,733 +5.5%
Stock-Based Compensation 62,157 71,718 -13.3%
Increase Decrease In Deferred Income Taxes 13,497 56 +24001.8%
Other Non-Cash Items 11,412 -4,229 +369.9%
Change in Accounts Receivable -128,497 -96,693 -32.9%
Change in Prepaid & Other Assets 65,038 65,746 -1.1%
Change in Inventory -4,859 -34,281 +85.8%
Change in Accounts Payable 32,976 19,050 +73.1%
Increase Decrease In Accrued Liabilities 138,545 129,769 +6.8%
Net Cash from Operations 543,301 381,218 +42.5%
Investing Activities
Proceeds From Sale Of Longterm Investments 0 1,915 -100.0%
Payments To Acquire Other Productive Assets -21,877 -17,384 -25.8%
Payments To Acquire Intangible Assets 0 0 —
Payments To Acquire Marketable Securities -82,655 -29,384 -181.3%
Proceeds From Sale And Maturity Of Marketable Securities 74,988 23,388 +220.6%
Net Cash from Investing -37,419 -21,465 -74.3%
Financing Activities
Proceeds From Stock Plans 160,209 33,059 +384.6%
Tax Withholding for Share Compensation -16,349 -886 -1745.3%
Finance Lease Principal Payments -1,158 -1,037 -11.7%
Net Cash from Financing 137,739 20,394 +575.4%
Supplemental
Unpaid Capital Expenditures 771 -941 +181.9%
Right Of Use Asset Obtained In Exchange For Operating Lease Liability 0 7,238 -100.0%
Right Of Use Asset Obtained In Exchange For Finance Lease Liability 499 6,947 -92.8%
Income Taxes Paid 26,957 -302,486.9 +108.9%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -801 3,458 -123.2%
Net Change in Cash 642,820 383,605 +67.6%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3,099,669 1,689,451 +83.5%

Values in thousands USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key